Are you sure you want to exit?
Any unsave changes will be lost.
Athersys
Laboratory
United States of America (USA), North America
Athersys is to Initiate a Pivotal Clinical Trial Evaluating MultiStem® Cell Therapy in Patients With COVID-19 Induced Acute Respiratory Distress Syndrome
https://www.athersys.com/investors/press-releases/press-release-details/2020/FDA-Authorizes-Athersys-to-Initiate-a-Pivotal-Clinical-Trial-Evaluating-MultiStem-Cell-Therapy-in-Patients-With-COVID-19-Induced-Acute-Respiratory-Distress-Syndrome/default.aspx